Johan Burisch on the costs of inflammatory bowel disease in high-income settings

The Lancet Gastroenterology & Hepatology in conversation with

English - April 12, 2023 10:00 - 20 minutes - 13.8 MB
Life Sciences Science Education gut intestines ibs ibd bowel medicine research Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease

Next Episode: Adelina Artenie on the incidence of HIV and HCV in people who inject drugs

Johan Burisch (Copenhagen University Hospital, Denmark) discusses the findings and recommendations of The Lancet Gastroenterology & Hepatology Commission on the cost of inflammatory bowel disease in high-income settings.

Read the Commission here:
The cost of inflammatory bowel disease in high-income settings

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv